Cargando…
Sorafenib plus doxorubicin in advanced hepatocellular carcinoma patients: hope or hype?
Autores principales: | Shing, Kit, Kwok, Gerry, Chiu, Joanne, Cheung, Tan To, Yau, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812207/ https://www.ncbi.nlm.nih.gov/pubmed/33490207 http://dx.doi.org/10.21037/atm-2020-130 |
Ejemplares similares
-
PCR for the diagnosis of sepsis: hope or hype?
por: Schrenzel, Jacques
Publicado: (2011) -
Nilotinib – Differentiating the Hope from the Hype
por: Wyse, Richard K., et al.
Publicado: (2016) -
Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
por: Lau, Harry Cheuk-Hay, et al.
Publicado: (2022) -
Hope and hype
por: De Clercq, Erik
Publicado: (2006) -
Help, hope and hype: ethical considerations of human microbiome research and applications
por: Ma, Yonghui, et al.
Publicado: (2018)